CClinicalTrials.gg
CompletedNCT00599456Updated May 10, 2017

Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.

An interventional study of Omega 3 fatty acid vitamins and Placebo capsules in Hot Flashes and Menopause, sponsored by Christiana Care Health Services. Completed at 1 site in United States. Open to female participants aged Up to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-05-10.

Sponsored by Christiana Care Health Services · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
Up to 65 Years
Sex
Female
01

Study summary

Hot flashes can be a disturbing symptom of menopause. Prescription medications are commonly used for symptom relief. Several non-prescription therapies are under investigation. This study will examine the use of omega-3 (fish oil) supplements to see if it helps relieve hot flashes and therefore improve the quality of life.

Study Hypotheses:

Menopausal women who take Omega 3 vitamins(fish oils)will show improvement in the severity of their hot flashes.In addition women who take Omega 3 supplements will show improvement in their lipid profiles.

Read the detailed description

This study requires you to have blood drawn twice, record your hot flashes for a total of 3 weeks, and to take a product every day for 12 weeks. It will also entail 4 visits and up to 4 telephone contacts. The information you provide will be maintained in a database accessible only to the primary investigator and research team. You will be assigned a code number for your blood work and all other information. The key to this code will be maintained in this database.

Overall 60-100 women will be recruited for this study locally. During the course of the study you will get overall two blood draws amounting to up to a teaspoon for measurement of your cholesterol and fat levels.

This project consists of three phases.

Phase I

We will ask you questions about your medical history and your health. You will then be asked to provide a urine sample which will be used to confirm your menopausal status with a FSH level. You will be requested to keep a record of your hot flashes for one week using a symptom diary. Upon completion of the diary, you will return to the study site. If you qualify for participation, you will have blood work done to measure your cholesterol and other fat levels through a lipid panel. You will be provided with these results free of charge at the conclusion of the study.

Phase 2

You will receive the study medication. Half of the participants will receive the actual product we are investigating and half will receive a placebo (inactive/dummy pill). Neither you nor the investigators will not know which one you are given until the end of the study. During the 4th and 12th weeks, you will be asked to keep a diary (similar to the first one) of your hot flashes.

Phase 3

At the end of the 12 week study period, you will return to the study center. The second blood draw will be done to monitor any changes. This will conclude your participation. You will be sent a copy of your cholesterol profiles and FSH levels approximately 2 weeks after you complete the study.

02

Conditions studied

  • Hot Flashes
  • Menopause

Browse trials for

Keywords

  • Hot flashes
  • Menopause
  • Omega 3 fatty Acids
03

In context

Hot Flashes

285 studies on the registry are indexed under Hot Flashes; 50 are open to participants now.

This study's planned enrollment of 100 is above the median of 90 across 255 interventional studies indexed under Hot Flashes.

Browse Hot Flashes studies →

Lead sponsor

Christiana Care Health Services is the lead sponsor of 94 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Post menopausal females (no periods for over 6 months)
  • Documented Serum FSH level>20
  • Positive urine FSH test
  • Hot flashes, on average five a day
  • A 2 week pre study washout period of exclusion criteria

Exclusion criteria

Exclusion Criteria:

  • No EPT/ET
  • OTC supplements: ex; soy, black cohosh, flax, bellergal, primrose oil, vitamin E, red clover
  • Excessive smoking > 1ppd
  • Anti seizure medications
  • Clonidine
  • Effexor
  • More than 2 servings of fish per week
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    1

    Omega 3 vitamin supplements

    Dietary Supplement: Omega 3 fatty acid vitamins

  • Placebo comparator
    2

    Placebo capsule

    Dietary Supplement: Placebo capsules

Interventions

  • Dietary supplementOmega 3 fatty acid vitamins

    Omega 3 fatty acid vitamins, 2 capsules, by mouth, daily, for 3 months

  • Dietary supplementPlacebo capsules

    Placebo capsules,2 capsules, by mouth, daily for 3 months

06

What researchers measure

Primary outcomes

  1. The decrease in the severity in hot flashes.

    Time frame: 3 months

Secondary outcomes

  1. Improvement in lipid profile

    Time frame: 3 months

07

Study locations

1 site
  • Christiana Care Health Systems
    Newark, Delaware 19718, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 10, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00599456
Lead sponsor
Christiana Care Health Services
Responsible party
Sponsor
First posted
Jan 23, 2008
Start date
Sep 2007
Primary completion
Sep 2009
Completion
Sep 2009
Last update
May 10, 2017

Study contacts

Parastoo Farhady, MD
principal investigator · Chrisitiana care Health Systems

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion